{"log_id": 7665978256540000016, "direction": 0, "words_result_num": 46, "words_result": [{"probability": {"variance": 0.000452, "average": 0.990651, "min": 0.893879}, "location": {"width": 683, "top": 239, "height": 23, "left": 223}, "words": "其它亚组指的是主要诊断为 NSCLC.但疾病不能明确符合腺癌、鳞状细胞痛或大细胞癌的患者"}, {"probability": {"variance": 0.0196, "average": 0.952052, "min": 0.441253}, "location": {"width": 712, "top": 269, "height": 22, "left": 222}, "words": "没有报告所有随机化患者的东部肿瘤协作组体能状态( ECOG PS)。在计算百分比时,培美曲塞组的"}, {"probability": {"variance": 0.001023, "average": 0.980551, "min": 0.901336}, "location": {"width": 134, "top": 299, "height": 22, "left": 268}, "words": "安慰剂组的N=22"}, {"probability": {"variance": 0.00461, "average": 0.974319, "min": 0.731468}, "location": {"width": 509, "top": 328, "height": 22, "left": 235}, "words": "牛非所有随机化患者均报告了吸烟史。在计算百分比时,培美曲塞组的"}, {"probability": {"variance": 0.000116, "average": 0.99313, "min": 0.965975}, "location": {"width": 127, "top": 328, "height": 20, "left": 808}, "words": "安慰剂组的N=22"}, {"probability": {"variance": 0.003851, "average": 0.98546, "min": 0.603683}, "location": {"width": 765, "top": 396, "height": 28, "left": 241}, "words": "患者接受培美曲塞的中位周期数为5,安慰剂的中位周期数为3.5。随机接受培美曲塞的患"}, {"probability": {"variance": 0.002315, "average": 0.98268, "min": 0.77979}, "location": {"width": 807, "top": 437, "height": 24, "left": 200}, "words": "者的相对剂量强度为95.7%总计213例患者(48.3%)完成了26个周期的培美曲塞治疗,总计98"}, {"probability": {"variance": 6.3e-05, "average": 0.994229, "min": 0.968746}, "location": {"width": 408, "top": 474, "height": 26, "left": 200}, "words": "例患者(22.6%)完成了10个周期的培美曲塞治疗"}, {"probability": {"variance": 0.001167, "average": 0.989015, "min": 0.769794}, "location": {"width": 767, "top": 521, "height": 26, "left": 239}, "words": "在总体试验人群中,培美曲塞组在总生存期(中位OS分别为13.4个月和10.6个月,HR=0.79"}, {"probability": {"variance": 0.005802, "average": 0.975131, "min": 0.458182}, "location": {"width": 804, "top": 567, "height": 26, "left": 201}, "words": "95%C:0.65-0.95),p-2=0.012)和无进展生存期(中位PFS分别为4.0个月和2.0个月:HR=0.60"}, {"probability": {"variance": 0.009311, "average": 0.955769, "min": 0.581125}, "location": {"width": 801, "top": 611, "height": 26, "left": 198}, "words": "(5%C1:0.49-0.73),p-2001)方面显著优于安慰剂。根据组织学分类,观察到了治疗结果"}, {"probability": {"variance": 0.000185, "average": 0.992723, "min": 0.941787}, "location": {"width": 773, "top": 655, "height": 24, "left": 198}, "words": "的差异。在非鳞状细胞非小细胞肺癌患者人群中,培美曲塞在总生存期(中位OS分别为15"}, {"probability": {"variance": 0.012884, "average": 0.961757, "min": 0.371028}, "location": {"width": 797, "top": 697, "height": 26, "left": 201}, "words": "个月和10.3个月,HR=0.70(95%C:0.560.88)和无进展生存期(中位PFS分别为4.4个月和"}, {"probability": {"variance": 0.000538, "average": 0.990203, "min": 0.874718}, "location": {"width": 781, "top": 743, "height": 25, "left": 210}, "words": "8个月,HR=0.47(95%CI:0.37-0.60)方面优于安慰剂。在鳞状细胞非小细胞肺癌患者人群中"}, {"probability": {"variance": 0.000219, "average": 0.992885, "min": 0.927469}, "location": {"width": 793, "top": 786, "height": 26, "left": 198}, "words": "与安慰剂相比,培美曲塞并不能改善总生存期(中位OS分别为9.9个月和10.8个月,HR=1.0"}, {"probability": {"variance": 0.001955, "average": 0.982841, "min": 0.701324}, "location": {"width": 709, "top": 830, "height": 24, "left": 196}, "words": "95%CI:0.77-1.50)或无进展生存期(中位PFS分别为2.4个月和2.5个月,HR=1.03"}, {"probability": {"variance": 0.001252, "average": 0.985784, "min": 0.836831}, "location": {"width": 786, "top": 873, "height": 27, "left": 195}, "words": "071-1.49)。不同组织学类型间培美曲塞的疗效差异表明培美曲塞对鳞状细胞癌缺乏疗效,在"}, {"probability": {"variance": 1e-06, "average": 0.999326, "min": 0.996497}, "location": {"width": 488, "top": 917, "height": 26, "left": 195}, "words": "线治疗和二线治疗的临床研究中也观察到了这一疗效差异"}, {"probability": {"variance": 2.1e-05, "average": 0.997407, "min": 0.97723}, "location": {"width": 763, "top": 961, "height": 27, "left": 235}, "words": "总体患者人群的有效性结果报告于表15和图3,根据预先设定的组织学亚组分析的有效性"}, {"probability": {"variance": 7e-06, "average": 0.998359, "min": 0.990417}, "location": {"width": 208, "top": 1005, "height": 26, "left": 193}, "words": "结果报告于表16和图4"}, {"probability": {"variance": 0.011314, "average": 0.963681, "min": 0.424258}, "location": {"width": 668, "top": 1049, "height": 26, "left": 192}, "words": "表15:维持治疗: NSCLC患者中培美曲塞与安慰剂的有效性比较IT人群"}, {"probability": {"variance": 1e-06, "average": 0.999302, "min": 0.997627}, "location": {"width": 102, "top": 1086, "height": 26, "left": 194}, "words": "有效性参数"}, {"probability": {"variance": 0.002977, "average": 0.966131, "min": 0.848148}, "location": {"width": 102, "top": 1086, "height": 26, "left": 549}, "words": "培美曲塞(N"}, {"probability": {"variance": 0.001951, "average": 0.97318, "min": 0.869938}, "location": {"width": 96, "top": 1088, "height": 25, "left": 793}, "words": "安慰剂(N=2"}, {"probability": {"variance": 0.000129, "average": 0.993239, "min": 0.963974}, "location": {"width": 143, "top": 1118, "height": 24, "left": 200}, "words": "中位总生存期(9"}, {"probability": {"variance": 0.002935, "average": 0.971704, "min": 0.813414}, "location": {"width": 100, "top": 1119, "height": 21, "left": 582}, "words": "个月(11.9-15"}, {"probability": {"variance": 0.000728, "average": 0.981744, "min": 0.922517}, "location": {"width": 130, "top": 1120, "height": 22, "left": 783}, "words": "0.6个月(8.7-12"}, {"probability": {"variance": 0.00017, "average": 0.99189, "min": 0.962961}, "location": {"width": 95, "top": 1149, "height": 23, "left": 194}, "words": "风险比(HR"}, {"probability": {"variance": 0.00011, "average": 0.991677, "min": 0.968778}, "location": {"width": 81, "top": 1152, "height": 19, "left": 692}, "words": "79(0.65-0"}, {"probability": {"variance": 0, "average": 0.999953, "min": 0.999953}, "location": {"width": 20, "top": 1182, "height": 20, "left": 214}, "words": "值"}, {"probability": {"variance": 8e-06, "average": 0.99795, "min": 0.989561}, "location": {"width": 216, "top": 1209, "height": 26, "left": 194}, "words": "中位无进展生存期(95%"}, {"probability": {"variance": 0.028891, "average": 0.916338, "min": 0.446248}, "location": {"width": 94, "top": 1209, "height": 25, "left": 569}, "words": ".0个月(3.-4"}, {"probability": {"variance": 0, "average": 0.998652, "min": 0.998173}, "location": {"width": 40, "top": 1211, "height": 25, "left": 820}, "words": "个月"}, {"probability": {"variance": 0.013308, "average": 0.952518, "min": 0.608748}, "location": {"width": 132, "top": 1241, "height": 24, "left": 194}, "words": "风险比(HR)(95"}, {"probability": {"variance": 0.005685, "average": 0.965695, "min": 0.718841}, "location": {"width": 104, "top": 1244, "height": 22, "left": 692}, "words": "60(0.49-0.73"}, {"probability": {"variance": 0.004714, "average": 0.921964, "min": 0.831128}, "location": {"width": 43, "top": 1273, "height": 26, "left": 189}, "words": "p-值"}, {"probability": {"variance": 3.1e-05, "average": 0.99765, "min": 0.976447}, "location": {"width": 277, "top": 1302, "height": 24, "left": 214}, "words": "从完成了4个周期的含铂化疗后的随机"}, {"probability": {"variance": 0.000143, "average": 0.985931, "min": 0.964745}, "location": {"width": 116, "top": 1302, "height": 23, "left": 573}, "words": "计算PS和OS"}, {"probability": {"variance": 0.042014, "average": 0.760613, "min": 0.499274}, "location": {"width": 95, "top": 1280, "height": 35, "left": 946}, "words": "果贸易"}, {"probability": {"variance": 0.01965, "average": 0.960536, "min": 0.366738}, "location": {"width": 305, "top": 1333, "height": 21, "left": 208}, "words": "PS的数值是基于独立分析结果(培美塞"}, {"probability": {"variance": 0.000118, "average": 0.992529, "min": 0.969454}, "location": {"width": 95, "top": 1334, "height": 19, "left": 580}, "words": "安慰剂N=19"}, {"probability": {"variance": 6.2e-05, "average": 0.991605, "min": 0.983721}, "location": {"width": 158, "top": 1310, "height": 38, "left": 936}, "words": "限公"}, {"probability": {"variance": 4.1e-05, "average": 0.995833, "min": 0.976353}, "location": {"width": 262, "top": 1363, "height": 22, "left": 199}, "words": "提供的为未校正的风险比。如果HR"}, {"probability": {"variance": 0.004941, "average": 0.961095, "min": 0.815577}, "location": {"width": 166, "top": 1362, "height": 22, "left": 601}, "words": "组的结果优于安慰剂组"}, {"probability": {"variance": 0.029782, "average": 0.856103, "min": 0.558853}, "location": {"width": 243, "top": 1424, "height": 107, "left": 698}, "words": "礼桌贸易"}, {"probability": {"variance": 0.028167, "average": 0.81495, "min": 0.64712}, "location": {"width": 75, "top": 1500, "height": 41, "left": 816}, "words": "公司"}], "language": 3}